Comparison of PENG Associated with LFCN Block Versus FICB for Multimodal Analgesic Management in THA
Pericapsular Nerve Group (PENG) Associated with Lateral Femoral Cutaneous Nerve (LFCN) Block Versus FIC Block for Total Hip Replacement Surgery: a Double Blind Randomized Controlled Trial
1 other identifier
interventional
58
1 country
1
Brief Summary
Optimal pain control with limited muscle weakness is paramount for a swift initiation of physical therapy and ambulation. Fascia iliaca compartment block (FIC) has been recommended since it offers the best pain control with low risk of motor block. Pericapsular nerve group block (PENG) with lateral femoral cutaneous block (LFCN) has been proposed as an effective alternative to FIB that offers similar pain control with a considerably lower risk of motor block. The aim of this study is to compare the afore mentioned blocks and determine which one yielded the least degree of quadriceps femoris muscle weakness and the better pain control (the lowest NRS score with least need for opioids).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 17, 2023
CompletedStudy Start
First participant enrolled
November 20, 2023
CompletedFirst Posted
Study publicly available on registry
November 27, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedDecember 18, 2024
December 1, 2024
5 months
November 17, 2023
December 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
MRC at 6h
evaluation of the degree of weakness or residual paresis of the quadriceps femoris muscle on the operative side using 'the Oxford Scale' (aka Medical Research Council Manual Muscle Testing scale or MRC scale) The MRC scale is a 0-5 scale, with zero meaning "no contraction " and five meaning "Full range of motion against gravity with full resistance".
six hours after performing the regional anesthesia technique
MRC at 24h
evaluation of the degree of weakness or residual paresis of the quadriceps femoris muscle on the operative side using 'the Oxford Scale' (aka Medical Research Council Manual Muscle Testing scale or MRC scale) The MRC scale is a 0-5 scale, with zero meaning "no contraction " and five meaning "Full range of motion against gravity with full resistance".
24 hours after performing the regional anesthesia technique
MRC at 48h
evaluation of the degree of weakness or residual paresis of the quadriceps femoris muscle on the operative side using 'the Oxford Scale' (aka Medical Research Council Manual Muscle Testing scale or MRC scale) The MRC scale is a 0-5 scale, with zero meaning "no contraction " and five meaning "Full range of motion against gravity with full resistance".
48 hours after performing the regional anesthesia technique
Secondary Outcomes (7)
time to first postoperative ambulation
From date of surgery until up to 72 hours after
Pain control at 6h
six hours after performing the regional anesthesia technique
Pain control at 24h
24 hours after performing the regional anesthesia technique
Pain control at 48h
48 hours after performing the regional anesthesia technique
MME of PRN opioid total doses
From date of surgery until up to 72 hours after
- +2 more secondary outcomes
Other Outcomes (4)
Complication
From date of surgery until up to 72 hours after
the degree of hip flexion
six hours after performing the regional anesthesia technique
the degree of hip flexion
24 hours after performing the regional anesthesia technique
- +1 more other outcomes
Study Arms (2)
PENG - LFCN Block
EXPERIMENTALgroup in which PENG and LFCN Block was performed. After performing neuraxial anesthesia, the PENG associated with LFCN block will be performed. Under ultrasound guidance, 20ml and 5ml of Ropivacaine 0.5% will be administered respectively.
FIC Block
ACTIVE COMPARATORgroup in which FIC Block was performed After performing neuraxial anesthesia, FIC block will be performed. Under ultrasound guidance, 20 ml of Ropivacaine 0.5% will be administered.
Interventions
The experimental arm will be subjected to a combination of peripheral blocks: the interfascial block of the PENG and the perinervous block of the LFCN The PENG block involves deposition of local anesthetic in the fascial plane between the psoas muscle and the superior pubic ramus. The LFCN block consists of applying local anesthetic near the nerve. The LFCN lies in the subcutaneous plane deep to the fascia lata below the anterior superior ischiatic spine.
The control arm will be subjected to an interfascial block, the fascia iliaca Compartment Block. The FICB consists in the injection of anaesthetic agents into the fascia iliaca compartment.
Eligibility Criteria
You may qualify if:
- elective total hip replacement surgery for non-traumatic hip disease,
- THA (total hip arthroplasty) with lateral approach
- age \>18 years,
- signed consent form for spinal anesthesia and peripheral nerve block provided by the patient or legal guardian if appointed
You may not qualify if:
- Non elective THA
- Lack of consent to the procedure
- Contraindications to performing neuraxial anesthesia (i.e. Signs suggestive of puncture site infection, INR \> 1.5, aPTT \> 1.5, PLT \< 40.000)
- Documented or suspected allergy to local anesthetics
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ospedale Edoardo Bassini
Cinisello Balsamo, Milano, 20092, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The anesthetist in the operating room will be the only one who knows what treatment has been administered Participant: the patient will not know the type of block he will be subjected to, because of he will already be subjected to neuraxial anesthesia. Outcomes Assessor: a clinician external to the practice will evaluate the degree of residual paralysis after anesthesia and pain control Investigator: the statistician will not know which anesthetic technique was administered to which group
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 17, 2023
First Posted
November 27, 2023
Study Start
November 20, 2023
Primary Completion
May 1, 2024
Study Completion
June 1, 2024
Last Updated
December 18, 2024
Record last verified: 2024-12